Advertisement

Index by author

September 01, 1984; Volume 26,Issue 2

  1. Albengres, E

    1. In vitro studies on the distribution of probucol among human plasma lipoproteins.
      S Urien, P Riant, E Albengres, R Brioude and J P Tillement
      Molecular Pharmacology September 1984, 26 (2) 322-327;

  2. Albuquerque, E X

    1. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
      S R Ikeda, R S Aronstam, J W Daly, Y Aracava and E X Albuquerque
      Molecular Pharmacology September 1984, 26 (2) 293-303;
    2. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Analysis of single-channel currents.
      Y Aracava, S R Ikeda, J W Daly, N Brookes and E X Albuquerque
      Molecular Pharmacology September 1984, 26 (2) 304-313;

  3. Aracava, Y

    1. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
      S R Ikeda, R S Aronstam, J W Daly, Y Aracava and E X Albuquerque
      Molecular Pharmacology September 1984, 26 (2) 293-303;
    2. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Analysis of single-channel currents.
      Y Aracava, S R Ikeda, J W Daly, N Brookes and E X Albuquerque
      Molecular Pharmacology September 1984, 26 (2) 304-313;

  4. Aronstam, R S

    1. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
      S R Ikeda, R S Aronstam, J W Daly, Y Aracava and E X Albuquerque
      Molecular Pharmacology September 1984, 26 (2) 293-303;

  5. Aub, D L

    1. Phorbol ester-induced protein secretion in rat parotid gland. Relationship to the role of inositol lipid breakdown and protein kinase C activation in stimulus-secretion coupling.
      J W Putney, J S McKinney, D L Aub and B A Leslie
      Molecular Pharmacology September 1984, 26 (2) 261-266;

  6. Bagley, J R

    1. Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro.
      V C Jordan, M E Lieberman, E Cormier, R Koch, J R Bagley and P C Ruenitz
      Molecular Pharmacology September 1984, 26 (2) 272-278;

  7. Beaujouan, J C

    1. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.
      J C Beaujouan, Y Torrens, A Viger and J Glowinski
      Molecular Pharmacology September 1984, 26 (2) 248-254;

  8. Bockaert, J

    1. Hormonal inhibition of adenylate cyclase. A crucial role for Mg2+.
      J Bockaert, B Cantau and M Sebben-Perez
      Molecular Pharmacology September 1984, 26 (2) 180-186;

  9. Brioude, R

    1. In vitro studies on the distribution of probucol among human plasma lipoproteins.
      S Urien, P Riant, E Albengres, R Brioude and J P Tillement
      Molecular Pharmacology September 1984, 26 (2) 322-327;

  10. Brookes, N

    1. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Analysis of single-channel currents.
      Y Aracava, S R Ikeda, J W Daly, N Brookes and E X Albuquerque
      Molecular Pharmacology September 1984, 26 (2) 304-313;
« Previous (Pages : 1 2 3 4 5 6 ... 12) Next »
Back to top

In this issue

Advertisement